• Pharma
  • June 25, 2025
  • 227 views
Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

  • Pharma
  • April 8, 2025
  • 341 views
Aurobindo Pharma arm gets European Commission authorization to market Dyrupeg in EU

Telangana:  Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for Dyrupeg, a pegylated filgrastim biosimilar, to CuraTeQ Biologics s.r.o., a…